Summary.-Adenosine deaminase and adenosine kinase have been measured in rat liver, 12 transplantable hepatomas, regenerating, foetal and neonatal liver, adult and neonatal rat kidney and 2 transplantable kidney tumours. Adenosine deaminase activity, relative to the normal liver value, was elevated 2-4-fold in hepatomas of rapid growth rate, was in the normal range in more slowly growing hepatomas and in regenerating liver, and was low in foetal and neonatal liver. Adenosine kinase activity was decreased, relative to rat liver values, in all the hepatomas; activity of this enzyme gave a negative correlation with tumour growth rate. Kinetic properties of the two enzymes were examined in partially purified preparations. Adenosine deaminases from both liver and rapidly growing hepatoma 3924A were subject to weak product inhibition by inosine. Adenosine kinase from liver and hepatoma 3924A was inhibited by the reaction products ADP and AMP, and the enzyme was also subject to excess substrate inhibition by concentrations of ATP in excess of 1 mM. In rat hepatoma cell lines growing in culture, the toxicity of adenosine correlated inversely with the ratio of adenosine deaminase activity to adenosine kinase activity. Chromatographic measurements showed that hepatoma cells incorporated less extracellular adenosine into their adenine nucleotide pools than did isolated liver cells. These results indicate that increased adenosine deaminase activity and decreased adenosine kinase activity may confer a selective advantage upon the cancer cell.
THE marked abnormalities in the purine metabolism of hepatomas and other tumours have been reviewed by Weber (1977) . In other systems there is experimental evidence suggesting that activity of adenosine deaminase (EC 3.5.4 .4, ADA), which converts adenosine to inosine, may correlate in some way with cell proliferation. Congenital deficiency of ADA is associated with the severe combined immunodeficiency syndrome (Giblett et al., 1972; Dissing and Knudsen, 1972; Parkman et al., 1975) . In peripheral lymphoid cells from patients with chronic lymphocytic leukaemia, ADA levels were in the normal range (Scholar and Calabresi, 1973) , but blast cells from patients with acute lymphoblastic leukaemia and acute myeloid leukaemia contained markedly higher ADA activity than normal peripheral leucocytes (Smyth and Harrap, 1975; Meier, Coleman and Hutton, 1976) . Reid and Lewin (1957) found that ADA activity in a primary azo-dye-induced hepatoma was in the same range as in normal liver, and DeLamirande, Allard and Cantero (1958) showed that ADA specific activity in Novikoff hepatoma was twice that of normal rat liver. These preliminary indications of a possible link between ADA activity and cell proliferation are of particular interest in view of the results of , who observed that adenosine was toxic to cultured mammalian cells by virtue of an interference with pyrimidine biosynthesis.
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The action of ADA is opposed by adenosine kinase (2.7.1.20, AK) which converts adenosine to adenosine 5'-monophosphate (AMP). Lund, Cornell and Krebs (1975) showed that addition of adenosine (0.5 mM) to suspensions of rat hepatocytes increased the intracellular concentration of adenine nucleotides up to 3-fold, indicating that AK was capable of incorporating considerable amounts of adenosine into the adenine nucleotide pool of rat liver cells during a 60 min incubation; nevertheless, under these conditions 80% of the added adenosine was deaminated by ADA. Chan et al. (1973) showed that a mutant fibroblast line, which lacked AK, excreted inosine and hypoxanthine into the tissueculture medium, and they suggested that AK, by opposing ADA, prevented the capacity of the other enzymes of the "adenosine cycle" from being exceeded. These observations suggested that it would be of value to examine the activities of the opposing enzymes, ADA and AK, in a spectrum of hepatomas of different growth rates, and in regenerating and foetal liver, and to attempt to relate the activity of the enzymes to the degree of adenosine toxicity, and the extent to which adenine nucleotide pools were altered in presence of adenosine. This paper presents data from these and other systems, and kinetic studies with partially purified enzymes, which attempt to clarify the role of these opposing enzymes in adenosine metabolism, and their relation to cell proliferation. MATERIALS (Higgins and Anderson, 1931) . For experiments with foetal and neonatal rats, and for tissue distribution studies, Wistar rats were used.
Tissue extraction.-Rats were stunned, decapitated and bled, tissues were excised, finely minced with scissors, and suspended in 0-25 M aqueous sucrose solution buffered to pH 7-2 with 0-02 M Tris HC1. Ten per cent (w/v) homogenates were prepared by homogenizing tissues for 30 sec at 600 rev/min in a Thomas tissue grinder fitted with a motor-driven teflon pestle. Homogenates were centrifuged for 1 h at 105,000 g, and the supernatant fraction (cytosol) was used for enzyme assays. The extracts were kept at 0-40C during and after preparation.
Adenosine deaminase assay.-The assay method was based on that of Kalekar (1947) . The sample euvette contained 2-35 ml of 0415 M potassium-phosphate buffer, pH 7 2, and 0u05 ml of enzyme preparation. Reference cuvettes contained 2-45 ml of the buffer and 0 05 ml of enzyme. After equilibration to 37°C, reaction was started by addition to the sample cuvette of 041 ml of 2-5 mm adenosine solution. The reaction was followed at 265 nm in a Cary model 118 CX double-beam spectrophotometer, fitted with an automatic multiple sample programmer and cuvette positioner. Under these conditions reaction rates were linear for at least 5 min, and proportionate to amount of enzyme up to at least 6 x the usual amount. The molar optical-density change at 265 nm for the ADA reaction was redetermined for the present study, at physiological conditions of pH and ionic strength, and found to be 8-5 x 103/cm. ADA rates measured in this way were about 72% of Vmax, for both liver and hepatoma enzymes. Higher rates could be obtained by using increased adenosine concentrations, but this resulted in greater interference from stray light, with consequent increase in optical noise and poorer reproducibility. Thus, ADA activity was determined as described above, (1976) and . Novikoff cells were the subline NISI-67 (Plagemann and Swim, 1966) . Hepatoma 7795 was used as the subline MHlCl (Richardson, Tashjian and Levine, 1969 Michaelis constants for adenosine of the ADA preparations was measured by 703 assaying the enzyme in triplicate at a range of adenosine concentrations (5, 10, 20, 35, 50, 75, 100, 150 and 250 jumol/l). Saturation curves were roughly hyperbolic, with no indication of high substrate inhibition. The Michaelis constants, as calculated by the method of Wilkinson (1961) were 37±4 ,molar (liver ADA) and 45±7 ptmolar (Hepatoma 3924A enzyme). Both liver and hepatoma ADA were subject to product inhibition by inosine; results for the rat liver enzyme are shown in double reciprocal form in Fig. 1 . The inhibition was competitive with adenosine, and Ki,siope, as calculated by the computer programme "COMP" (Cleland, 1963) optimal level in the present study when measured at an ATP concentration of 1 mm. The ATP saturation curve for the liver enzyme is shown in Fig. 2 (Table III) , both enzymes, on this basis, had lower activity in the foetal or neonatal liver than in adult liver. It was interesting to compare the ratio ADA/AK at the various stages of development, since this ratio is independent of the units of the individual activities; the ADA/AK ratio in the 17-day foetal liver was 1*5 (3 7 x the adult liver ratio), declining with increasing age, and approaching the adult value by 31 days after birth. Table III also shows ADA and AK activities in neonatal kidney. Specific activity of ADA was higher, and that of AK lower, in neonatal kidney than in adults. Activities of both enzymes were lower in the neonatal kidney, on a percell basis, than in adult kidney cortex. As with the liver, the ratio of ADA/AK was higher in neonatal kidney than in the mature organ.
Growth inhibition of cultured hepatokna cells by adenosine Fig. 5 summarizes the growth-inihibitory effect of adenosine against 5 rat hepatoma lines in culture. It was shown by that the growth-inhibitory effect of adenosine is cell-density depend_444_jA-. (1975) showed that incubation of isolated rat hepatocytes with adenosine produced large increases in cellular ATP, and smaller increases in ADP and AMP. We designed similar experiments using Hepatoma 8999R and Novikoff cell lines, to determine the extent to which this response to adenosine is modified by the changes in activity of the competing enzymes ADA and AK, as observed in hepatomas. Isolated normal hepatocytes 709 and cultured 8999R and Novikoff hepatoma cells were incubated in McCoy's Medium 5A (,3 x 107 cells/5 ml) supplemented with 10% horse serum, and containing various concentrations of 3H-labelled adenosine (40 mCi/mmol). After 60 min at 37°C, cells were extracted with 4.5% perchloric acid, and extracts were neutralized with 4 N KOH, and analysed for ATP, ADP and AMP by the chromatographic method of Khym (1975) . The radioactivity in each of these peaks was measured by scintillation counting. Loss of adenosine from the incubation medium was measured optically, as described by Moellering and Bergmeyer (1974) . Data are shown in Table V . Results with hepatocytes at the highest adenosine concentration studied (300 ,M) were similar to the results obtained by Lund et al. (1975) with 500 ,uM adenosine: total adenine nucleotides increased by more than 100%, most of the increase being ATP. Twenty per cent of the adenosine utilized was recovered as adenine nucleotides, the remainder presumably being deaminated. At the lower adenosine concentrations studied (10 and 30 uM) more than half the adenosine was recovered in adenine nucleotides. In cells of Hepatoma 8999R, 60 min incubation with 300 /M adenosine gave a 40% increase in adenine nucleotides. At this adenosine level, 90% was deaminated, and the proportion of adenosine deaminated at the lower concentrations studied was higher than in liver. In Novikoff cells the effect of extracellular adenosine on adenine nucleotide levels was even smaller, and most of the adenosine was deaminated at all 3 concentrations studied. Although it is possible that some of the radioactive adenine nucleotides were formed by the (Jackson, Morris and Weber, 1977) and the proportion of adenosine label recovered in adenine nucleotides showed a good correlation with the ADA/AK ratio in the 3 cell types.
D)1SCUSSION
The examiniation of kinetic properties of ADA and AK suggests that the metabolic fate of adenosine is controlled by at least 3 factors. The first is the ratio of activities of these 2 competing enzymes. The elucidation of the behaviour of the activities of these enzymes in normal and neoplastic tissues was the primary aim of the present study, and the conclusions will be discussed in detail below. The second controlling factor is the ratio of Km values for the 2 enzymes. The very low Km for adenosine of AK (1 .3 Mm), compared to the higher value of ADA (37 yuM), ensures that adenosine is conserved at low concentrations. Data in Table V show that the proportion of adenosine deaminated increased with concentration. This arrangement may enable the cell to recycle small amounts of adenosine resulting from cellular AMP phosphatase activity, whilst protecting it from the toxic effects of high extracellular adenosine production. The third factor that controls adenosine utilization is the feedback inhibition of AK by AMP, ADP and ATP. Data shown in Table I and Fig. 2 indicate that these effects are appreciable at physiological nucleotide levels, though these inhibitions do not provide a completely effective homoeostatic mechanism, since incubation of cells with high concentrations of adenosine led to an elevated cellular adenine-nucleotide content. The product inhibition of ADA by inosine was feeble, and may be considered as of no physiological importance.
The results of the ADA tissue and organ distribution study (Table 11) closely resembled earlier surveys of this enzyme in rat tissues (Clarke et al., 1952; Purzycka, 1962; Brady and O'Donovan, 1965 The changes in activity of ADA and AK cannot be regarded as stringently linked with the neoplastic transformation. Activity ofADA showed no significant change in the slow-growing hepatomas (Fig. 3) and low values in peripheral leucocytes from chronic lymphocytic leukaemia (Scholar and Calabresi, 1973; Meier, Coleman and Hutton, 1976) . However, the marked increases of ADA activity in rapidly growing hepatomas (Fig. 3) anid in acute leukaemia cells (Smyth and Harrap, 1975; Meier et al., 1976) suggest that this enzyme may correlate with the process of malignant progression. A lack of correlation of ADA activity with cell proliferation per se seems to be indicated by the unchanged values in regenerating liver and neonatal liver. On the other hand, AK, which exhibited a negative correlation with growth rate in the hepatomas, also showed a marked and statistically significant decrease in regenerating liver, and was low in foetal and neonatal liver. The decrease in AK activity is thus found in both malignant and nonmalignant states of cell proliferation, though it was most marked in the rapidly-growing hepatomas. The changes which we observed in ADA and AK activities appear to be quantitative; no differences in kinetic or chromatographic properties were seen when the two enzymes were partially purified from rat liver and Hepatoma 3924A. The question whether multiple forms of these enzymes occur in rat liver and hepatomas will fortm the basis of future studies.
The reciprocal behaviour of the opposing enzymes ADA and AK, most markedly expressed in the rapidly growing neoplasms, is in line with previous observations on the behaviour of antagonistic enzymes in carbohydrate, purine and pyrimidine metabolism (Weber, 1977) . The changes reported above in activity of the competing enzymes ADA and AK should confer a selective advantage upon hepatoma cells in the presence of extracellular adenosine. That ADA activity influences adenosine toxicity was demonstrated by Harrap and Paine (1977) , who showed that coformycin, a potent and specific inhibitor of ADA, greatly increased the sensitivity of lymphoblasts to adenosine. In solid tumours, which often contain areas of necrotic tissue, the adenosine concentration might be appreciable, and the protection from adenosine toxicity afforded by increased deamination and reduced phosphorylation could have a marked effect on tumour survival. To establish the magnitude of adenosine toxicity in vivo, direct measurement of tissue adenosine levels will be necessary. This work was supported by research grants fiom the U)nited States Public Health Service (CA 13526, CA 05034, and CA 10792) . The authors are grateful to Mr L. Soliven for skilled technical assistance.
